Skip to content

Connecting business. Building understanding. Advancing peace.

Insilico Medicine

China–UAE News
Source: Bioengineer.org

Insilico Medicine to Showcase AI Drug Discovery Platforms in Dubai and London

Biotechnology firm Insilico Medicine announced its leadership will present advancements in artificial intelligence drug discovery and laboratory robotics at conferences in Dubai and London. Co-Founder and President Dr. Alex Aliper is scheduled to deliver a keynote at Dubai Future Week on closed-loop AI and robotic laboratories. Founder and CEO Dr. Alex Zhavoronkov will participate in panels in London examining China's biopharmaceutical innovation sector.

China–UAE News
Source: News-Medical

Insilico Medicine Leaders to Share AI Drug Discovery Insights in Shanghai and Dubai

Insilico Medicine announced that its senior leadership will present at major healthcare and AI summits across China and Dubai in November 2026. Global Business Development Head Dr. Jue Wang will speak in Shanghai, while Co-Founder and President Dr. Alex Aliper will join an investor panel in Dubai. The company also reported nominating 11 preclinical drug candidates in the first ten months of 2026.

Industry News
Source: Big News Network.com

UAE Investments in AI and Genomics Drive Middle East Biopharma Expansion

A report by World Health Expo and Frost & Sullivan indicates that UAE national investments in genomics, artificial intelligence, and advanced manufacturing are transforming Middle Eastern biopharma. The regional precision medicine sector is forecast to expand by over 10 percent over the next five to seven years. Key initiatives include the Emirati Genome Program, Abu Dhabi's AED 42 billion HELM cluster, and the 2025 launch of Mubadala Bio.

The UECN Brief

Policy updates, China–UAE business news and industry insights, delivered to your inbox.

Language
Subscriptions

Double opt-in: we send a confirmation link. Unsubscribe at any time. Privacy